002382 蓝帆医疗
交易中 08-10 11:17:21
资讯
新帖
简况
蓝帆医疗：柏盛国际是公司转型升级拓展至心脑血管器械领域的核心战略平台
证券之星 · 07-29
蓝帆医疗：柏盛国际是公司转型升级拓展至心脑血管器械领域的核心战略平台
蓝帆医疗：增持系基于对公司内在价值的认可
证券之星 · 07-29
蓝帆医疗：增持系基于对公司内在价值的认可
蓝帆医疗：两大主业全面盈利与前期战略举措成效集中释放
证券之星 · 07-29
蓝帆医疗：两大主业全面盈利与前期战略举措成效集中释放
蓝帆医疗：本次出售武汉必凯尔100%股权事项无需提交公司股东会审议
证券之星 · 07-29
蓝帆医疗：本次出售武汉必凯尔100%股权事项无需提交公司股东会审议
异动快报：蓝帆医疗（002382）7月15日9点33分触及涨停板
证券之星 · 07-15
异动快报：蓝帆医疗（002382）7月15日9点33分触及涨停板
股市必读：蓝帆医疗（002382）预计2026年1-6月每股收益盈利:0.09元至0.11元
证券之星 · 07-15
股市必读：蓝帆医疗（002382）预计2026年1-6月每股收益盈利:0.09元至0.11元
蓝帆医疗（002382）披露2026年半年度业绩预告，7月14日股价上涨4.43%
证券之星 · 07-14
蓝帆医疗（002382）披露2026年半年度业绩预告，7月14日股价上涨4.43%
股市必读：蓝帆医疗（002382）7月10日董秘有最新回复
证券之星 · 07-13
股市必读：蓝帆医疗（002382）7月10日董秘有最新回复
蓝帆医疗：整体报价维持行业内相对高位区间
证券之星 · 07-10
蓝帆医疗：整体报价维持行业内相对高位区间
蓝帆医疗：本次交易是公司为进一步聚焦核心主业、增厚现金储备、盘活存量资产、缩短管理半径，而基于中长期战略规划做出的主动安排
证券之星 · 07-10
蓝帆医疗：本次交易是公司为进一步聚焦核心主业、增厚现金储备、盘活存量资产、缩短管理半径，而基于中长期战略规划做出的主动安排
蓝帆医疗折价卖“子”回血，*ST明德溢价接盘“求生”，标的盈利下滑让双赢前景成谜
证券之星 · 07-06
蓝帆医疗折价卖“子”回血，*ST明德溢价接盘“求生”，标的盈利下滑让双赢前景成谜
蓝帆医疗：法院已做出相关判决
证券之星 · 07-03
蓝帆医疗：法院已做出相关判决
蓝帆医疗：心脑血管板块持股83.61%
证券之星 · 07-03
蓝帆医疗：心脑血管板块持股83.61%
1.9亿急救包资产易主：蓝帆医疗“断臂”回血，接盘方身陷退市风险
市场资讯 · 07-03
1.9亿急救包资产易主：蓝帆医疗“断臂”回血，接盘方身陷退市风险
股市必读：蓝帆医疗（002382）7月2日董秘有最新回复
证券之星 · 07-03
股市必读：蓝帆医疗（002382）7月2日董秘有最新回复
蓝帆医疗：全力推进高息负债置换工作
证券之星 · 07-02
蓝帆医疗：全力推进高息负债置换工作
蓝帆医疗：公司生产经营正常有序开展
证券之星 · 07-02
蓝帆医疗：公司生产经营正常有序开展
蓝帆医疗：手套业务盈利能力较2025年显著改善
证券之星 · 07-02
蓝帆医疗：手套业务盈利能力较2025年显著改善
蓝帆医疗：截至2026年6月30日，公司股东人数为64,101位
证券之星 · 07-02
蓝帆医疗：截至2026年6月30日，公司股东人数为64,101位
蓝帆医疗：公司将按照深交所上市规则关于业绩预告的相关披露要求，及时履行信息披露义务
证券之星 · 07-02
蓝帆医疗：公司将按照深交所上市规则关于业绩预告的相关披露要求，及时履行信息披露义务
暂无数据
公司概况
公司名称：
蓝帆医疗股份有限公司
所属行业：
专用设备制造业
上市日期：
2010-04-02
主营业务：
蓝帆医疗股份有限公司的主营业务是心脑血管业务、健康防护业务及护理业务。公司的主要产品是心脑血管产品、健康防护产品、应急救护产品。
发行价格：
35.00
{"stockData":{"symbol":"002382","market":"SZ","secType":"STK","nameCN":"蓝帆医疗","latestPrice":6.07,"timestamp":1786331841000,"preClose":5.98,"halted":0,"volume":8829600,"delay":0,"changeRate":0.0151,"floatShares":998000000,"shares":1008000000,"eps":-0.8288,"marketStatus":"交易中","change":0.09,"latestTime":"08-10 11:17:21","open":5.99,"high":6.08,"low":5.96,"amount":53327700,"amplitude":0.0201,"askPrice":6.07,"askSize":798,"bidPrice":6.06,"bidSize":197,"shortable":0,"etf":0,"ttmEps":-0.8288,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786332600000},"marketStatusCode":2,"adr":0,"adjPreClose":5.98,"symbolType":"stock","openAndCloseTimeList":[[1786325400000,1786332600000],[1786338000000,1786345200000]],"highLimit":6.58,"lowLimit":5.38,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1007590726,"isCdr":false,"pbRate":0.87,"roa":"--","roe":"0.01%","epsLYR":-0.76,"committee":-0.270558,"marketValue":6116000000,"turnoverRate":0.0088,"status":0,"floatMarketCap":6057000000},"requestUrl":"/m/hq/s/002382/tweets","defaultTab":"tweets","newsList":[{"id":"2655898078","title":"蓝帆医疗：柏盛国际是公司转型升级拓展至心脑血管器械领域的核心战略平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2655898078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655898078?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:51","pubTimestamp":1785329495,"startTime":"0","endTime":"0","summary":"柏盛国际是公司转型升级拓展至心脑血管器械领域的核心战略平台，该公司搭建了全球化研发、生产、销售完整体系，为蓝帆医疗形成了第二主业增长曲线。截至目前宏达热电运营良好，为公司手套业务今年以来满产全销、扭亏为盈做出了有力贡献，公司未有出售该资产的计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900037991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0251","BK0114","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655893838","title":"蓝帆医疗：增持系基于对公司内在价值的认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2655893838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655893838?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:51","pubTimestamp":1785329494,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月28日在投资者关系平台上答复投资者关心的问题。蓝帆医疗回复：您好，现就您提出的问题逐一回复：1、本次实际控制人及管理层增持均使用个人自有或自筹资金，增持为个人行为，系基于对公司内在价值的认可和未来持续稳定健康发展的坚定信心以及维护股东利益和增强投资者信心而作出增持决定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900037989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0077","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655932834","title":"蓝帆医疗：两大主业全面盈利与前期战略举措成效集中释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2655932834","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655932834?lang=zh_cn&edition=full","pubTime":"2026-07-29 08:54","pubTimestamp":1785286449,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月28日在投资者关系平台上答复投资者关心的问题。后续展望方面，健康防护业务得益于热电联产、产线升级及行业回暖等因素，盈利弹性将持续释放；心脑血管业务随着多款创新产品上市放量、海外代理业务拓展及战略合作项目推进，预计将保持稳健增长。公司将持续推进降本增效，优化总部费用结构，推动两大主业双轮驱动，提升整体盈利能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900007489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0114","BK0077","002382"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655834665","title":"蓝帆医疗：本次出售武汉必凯尔100%股权事项无需提交公司股东会审议","url":"https://stock-news.laohu8.com/highlight/detail?id=2655834665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655834665?lang=zh_cn&edition=full","pubTime":"2026-07-29 08:52","pubTimestamp":1785286328,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)07月28日在投资者关系平台上答复投资者关心的问题。投资者提问：必凯尔的出售股东会何时过会？款收取情况如何？何时讲收到款项？蓝帆医疗回复：您好，本次出售武汉必凯尔100%股权事项无需提交公司股东会审议，已经2026年6月29日召开的公司第六届董事会第四十三次会议审议通过，公司将会同交易对手方依据监管要求有序披露相应进展，您也可同步关注交易对手方的相应公告。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900007484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0251","002382","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651292438","title":"异动快报：蓝帆医疗（002382）7月15日9点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651292438","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651292438?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:35","pubTimestamp":1784079338,"startTime":"0","endTime":"0","summary":"证券之星7月15日盘中消息，9点33分蓝帆医疗（002382）触及涨停板。其所属行业医疗器械目前上涨。领涨股为九安医疗。该股为医疗器械，流感，互联网医疗概念热股，当日医疗器械概念上涨0.6%，流感概念上涨0.57%，互联网医疗概念上涨0.56%。7月14日的资金流向数据方面，主力资金净流入1689.03万元，占总成交额20.05%，游资资金净流出440.79万元，占总成交额5.23%，散户资金净流出1248.23万元，占总成交额14.82%。近5日资金流向一览见下表：蓝帆医疗主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500011415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","BK0077","002382"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651488247","title":"股市必读：蓝帆医疗（002382）预计2026年1-6月每股收益盈利:0.09元至0.11元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651488247","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651488247?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:14","pubTimestamp":1784049250,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，蓝帆医疗报收于5.42元，上涨4.43%，换手率1.59%，成交量15.87万手，成交额8422.06万元。公司公告汇总：健康防护事业部预计实现净利润2.5–3.0亿元，心脑血管事业部预计实现净利润约0.9亿元。公司公告汇总2026年半年度业绩预告预计2026年上半年归属于上市公司股东的净利润为9000万元至1.1亿元，同比扭亏为盈；扣除非经常性损益后的净利润为1.7亿元至2.3亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500001722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0077","002382","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104317","title":"蓝帆医疗（002382）披露2026年半年度业绩预告，7月14日股价上涨4.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104317","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651104317?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:17","pubTimestamp":1784038639,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，蓝帆医疗报收于5.42元，较前一交易日上涨4.43%，最新总市值为54.61亿元。该股当日开盘5.18元，最高5.42元，最低5.13元，成交额达8422.06万元，换手率为1.59%。公告显示，公司预计2026年上半年实现归属于上市公司股东的净利润9,000万元至1.1亿元，同比扭亏为盈；扣除非经常性损益后的净利润为1.7亿元至2.3亿元。公司总部费用及利息支出等合计负向影响约1.5亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002382","BK0077","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651166348","title":"股市必读：蓝帆医疗（002382）7月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651166348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651166348?lang=zh_cn&edition=full","pubTime":"2026-07-13 02:10","pubTimestamp":1783879819,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，蓝帆医疗报收于5.24元，上涨2.14%，换手率1.62%，成交量16.21万手，成交额8436.02万元。董秘最新回复投资者： 您好，贵司2020年2.86亿收购的公司，今年1.9亿卖掉，并且还是营收和利润一直在增长的情况下。预计本次交易不存在投资亏损，投资回报符合预期。董秘： 您好，根据相关业务规则，对应2026年6月15日查询口径的股东名册，基准日为2026年6月18日，对应的股东人数为65,053位，感谢您的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300001089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0251","002382","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185606","title":"蓝帆医疗：整体报价维持行业内相对高位区间","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650185606?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:51","pubTimestamp":1783673466,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)07月10日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的手套有涨价吗？相比年初涨幅是多少？蓝帆医疗回复：您好，目前公司手套产能保持满产满销，整体报价维持行业内相对高位区间，健康防护业务盈利能力较2025年显著改善。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0077","002382","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185579","title":"蓝帆医疗：本次交易是公司为进一步聚焦核心主业、增厚现金储备、盘活存量资产、缩短管理半径，而基于中长期战略规划做出的主动安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650185579?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:48","pubTimestamp":1783673294,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月10日在投资者关系平台上答复投资者关心的问题。公司针对该公司所进行的此前收购交易和本次出售交易，两次交易发生节点的宏观市场环境、公司经营策略等因素均有不同。本次交易是公司为进一步聚焦核心主业、增厚现金储备、盘活存量资产、缩短管理半径，而基于中长期战略规划做出的主动安排。预计本次交易不存在投资亏损，投资回报符合预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","002382","BK0077","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649764408","title":"蓝帆医疗折价卖“子”回血，*ST明德溢价接盘“求生”，标的盈利下滑让双赢前景成谜","url":"https://stock-news.laohu8.com/highlight/detail?id=2649764408","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649764408?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:14","pubTimestamp":1783325676,"startTime":"0","endTime":"0","summary":"若未达标，蓝帆医疗应在承诺期期满后以现金方式对*ST明德进行补偿；若承诺期满后标的资产期末减值额高于已补偿金额，蓝帆医疗还需另行补偿。受疫情导致防疫物资需求大涨的影响，蓝帆医疗2020年创下归属净利润17.58亿元的历史最好成绩，2021年营收虽创新高，但盈利已现下滑趋势。疫情红利消退业绩“断崖式”暴跌，*ST明德“借道”求生与蓝帆医疗脱手“回血”不同的是，*ST明德出手接盘意在寻求突围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026070600021317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0251","BK0239","BK0077","002382","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648666201","title":"蓝帆医疗：法院已做出相关判决","url":"https://stock-news.laohu8.com/highlight/detail?id=2648666201","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648666201?lang=zh_cn&edition=full","pubTime":"2026-07-03 20:51","pubTimestamp":1783083094,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月02日在投资者关系平台上答复投资者关心的问题。您提及的案件系双方业务接洽过程中产生的商事纠纷，法院已做出相关判决，结合案件性质及影响评估，预计不会对公司股票交易价格、日常经营产生重大不利影响，未触发临时披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300043001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0077","002382","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648266603","title":"蓝帆医疗：心脑血管板块持股83.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648266603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648266603?lang=zh_cn&edition=full","pubTime":"2026-07-03 20:51","pubTimestamp":1783083089,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月02日在投资者关系平台上答复投资者关心的问题。谢谢蓝帆医疗回复：您好，感谢您对公司的持续关注，公司两大板块对应的核心运营主体目前均仍为公司控股子公司，继续纳入合并报表范围，具体情况如下：心脑血管板块，核心持股主体为北京蓝帆柏盛医疗科技股份有限公司，经过A1轮、A2轮投资及债转股，目前公司对蓝帆柏盛的合计持股比例为83.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300042994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002382","BK0077","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648630047","title":"1.9亿急救包资产易主：蓝帆医疗“断臂”回血，接盘方身陷退市风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2648630047","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648630047?lang=zh_cn&edition=full","pubTime":"2026-07-03 11:00","pubTimestamp":1783047600,"startTime":"0","endTime":"0","summary":" 近日，蓝帆医疗发布公告，公司拟将持有的武汉必凯尔救助用品有限公司100%股权转让给*ST明德（维权），转让价格为1.9亿元。本次交易完成后，公司不再持有武汉必凯尔股权，武汉必凯尔将不再纳入合并报表范围。截至2025年末，武汉必凯尔资产总额23333.49万元，净资产11940.67万元。综合考虑持有期间的利润贡献、已获分红及本次1.9亿元转让对价，蓝帆医疗预计本次转让不会导致投资亏损。 蓝帆医疗此次“断臂”的决策，源于其面临的经营困境。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/2026-07-03/doc-inifnxny5621154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","002382","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648633836","title":"股市必读：蓝帆医疗（002382）7月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648633836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648633836?lang=zh_cn&edition=full","pubTime":"2026-07-03 04:19","pubTimestamp":1783023549,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，蓝帆医疗报收于5.23元，下跌0.95%，换手率1.54%，成交量15.37万手，成交额8093.95万元。投资者： 请问最新的股东人数董秘： 您好，截至2026年6月30日，公司股东人数为64,101位，感谢您的关注。投资者： 1.根据蓝帆第一季度发布时说的第二季度利润集中释放，那么7月是否应该提前发布年中预告董秘： 您好，公司将按照深交所上市规则关于业绩预告的相关披露要求，及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300005330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0114","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648360503","title":"蓝帆医疗：全力推进高息负债置换工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2648360503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648360503?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:51","pubTimestamp":1782982269,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，贵公司还完可转债之后剩余高息负债还挺多，贵公司有什么举措来筹措一些低息贷款置换高息贷款吗？否则一直还高额利息，有点拖累业绩，进而影响市值，影响融资，恶性循环。蓝帆医疗回复：您好，优化债务结构、压降融资成本为公司常态化财务管理工作，可转债兑付完成后，公司将结合资金现状、存量负债情况及经营改善安排，全力推进高息负债置换工作。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200027498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","002382","BK0077","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648350878","title":"蓝帆医疗：公司生产经营正常有序开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2648350878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648350878?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:42","pubTimestamp":1782981734,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司在正常运转吗？有没有裁员计划蓝帆医疗回复：您好，公司生产经营正常有序开展，持续引进专业人才，员工结构整体稳定。员工是公司重要的生产力和宝贵的财富，公司非常重视与员工共同发展、共同成长，致力为员工创建一个良好的发展平台，感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200027271.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0251","BK0114","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648712508","title":"蓝帆医疗：手套业务盈利能力较2025年显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2648712508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648712508?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:42","pubTimestamp":1782981730,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗07月02日在投资者关系平台上答复投资者关心的问题。这个不是什么保密信息，看市场上丁腈已经跌回2025年水平了？近期丁腈、PVC手套报价随上游原料行情、海外市场供需持续动态波动。目前公司手套产能保持满产满销，整体报价维持行业内相对高位区间，手套业务盈利能力较2025年显著改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200027265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0251","BK0114","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648508220","title":"蓝帆医疗：截至2026年6月30日，公司股东人数为64,101位","url":"https://stock-news.laohu8.com/highlight/detail?id=2648508220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648508220?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:39","pubTimestamp":1782981546,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新的股东人数蓝帆医疗回复：您好，截至2026年6月30日，公司股东人数为64,101位，感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200027205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0114","BK0251","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648508203","title":"蓝帆医疗：公司将按照深交所上市规则关于业绩预告的相关披露要求，及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2648508203","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648508203?lang=zh_cn&edition=full","pubTime":"2026-07-02 16:39","pubTimestamp":1782981544,"startTime":"0","endTime":"0","summary":"证券之星消息，蓝帆医疗(002382)07月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价最近一直跌跌不休，为提振公司股价，建议贵司尽快公布中期业绩预告，最好能在7月1号第一家发布蓝帆医疗回复：您好，公司将按照深交所上市规则关于业绩预告的相关披露要求，及时履行信息披露义务。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200027204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002382","BK0077","BK0251","BK0114"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786331844442,"stockEarnings":[{"period":"1week","weight":0.0275},{"period":"1month","weight":0.1612},{"period":"3month","weight":-0.1554},{"period":"6month","weight":0.0017},{"period":"1year","weight":-0.0553},{"period":"ytd","weight":0.0679}],"compareEarnings":[{"period":"1week","weight":0.0281},{"period":"1month","weight":-0.0078},{"period":"3month","weight":-0.0574},{"period":"6month","weight":-0.0309},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0073}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"蓝帆医疗股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"64101人(较上一季度减少1.46%)","perCapita":"15565股","listingDate":"2010-04-02","address":"山东省淄博市临淄区稷下街道一诺路48号","registeredCapital":"100759万元","survey":" 蓝帆医疗股份有限公司的主营业务是心脑血管业务、健康防护业务及护理业务。公司的主要产品是心脑血管产品、健康防护产品、应急救护产品。","listedPrice":35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"蓝帆医疗(002382)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供蓝帆医疗(002382)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"蓝帆医疗,002382,蓝帆医疗股票,蓝帆医疗股票老虎,蓝帆医疗股票老虎国际,蓝帆医疗行情,蓝帆医疗股票行情,蓝帆医疗股价,蓝帆医疗股市,蓝帆医疗股票价格,蓝帆医疗股票交易,蓝帆医疗股票购买,蓝帆医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"蓝帆医疗(002382)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供蓝帆医疗(002382)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}